4basebio and Genezen Partner to Develop Synthetic DNA Platforms for Viral Vector Manufacturing

Biotech firms 4basebio and Genezen have formed a strategic alliance to advance cell-free, synthetic DNA technologies aimed at improving next-generation viral vector production.

26 Aug, 06:20 — 26 Aug, 06:20

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual6d ago

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing - Taiwan News

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing Taiwan News

Read full article →

4basebio and Genezen Partner to Develop Synthetic DNA Platforms for Viral Vector Manufacturing

Sources

4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing - Taiwan News

Related Stories

Apple Maps Renames Lake Ontario to 'Lake America,' Sparking Public Backlash

Former Ukrainian Defense Minister Launches Defense Tech Firm Backed by Palantir

Palo Alto Networks Beats Earnings Estimates on Strong AI Cybersecurity Demand

MongoDB Beats Q2 Estimates but Shares Fall on AI Cost Concerns